C4 Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
C4 Therapeutics Inc
TickerCCCC
CIK #0001662579
CUSIP12529R107
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address490 Arsenal Way Suite 200, Watertown, MA 02472
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
C4 Therapeutics Inc 2016-01-11 70.3 M Exemption: 506(b) · Remaining: $3,170,000 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001662579] 10-K
[0001662579] 10-Q
[0001662579] 3
[0001662579] 4
[0001662579] 8-K
[0001662579] D
[0001662579] SC 13D
[0001662579] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Squadron Capital Management LLC C4 Therapeutics Inc [2026-05-19] 0.0
Sirenia Capital Management LP C4 Therapeutics Inc [2026-05-15] 0.0
Bain Capital Life Sciences Fund II LP C4 Therapeutics Inc [2025-10-24] 0.0
RA Capital Management LP C4 Therapeutics Inc [2025-10-24] 0.0
Point72 Asset Management LP C4 Therapeutics Inc [2025-10-20] 0.0
Morgan Stanley C4 Therapeutics Inc [2025-02-03] 0.0
OrbiMed Advisors LLC C4 Therapeutics Inc [2024-11-14] 2.1
BlackRock Inc C4 Therapeutics Inc [2024-11-08] 7.1
BlackRock Inc C4 Therapeutics Inc [2024-10-22] 7.1
State Street Corp C4 Therapeutics Inc [2024-04-10] 10.43
Soleus Capital Master Fund LP C4 Therapeutics Inc [2024-02-05] 5.2
Betta Investment Hong Kong Ltd C4 Therapeutics Inc [2024-01-12] 8.1
Point72 Asset Management LP C4 Therapeutics Inc [2024-01-04] 4.7
RA Capital Management LP C4 Therapeutics Inc [2023-12-26] 9.9
Commodore Capital LP C4 Therapeutics Inc [2023-12-22] 7.7
Lynx1 Capital Management LP C4 Therapeutics Inc [2023-11-13] 6.3
Millennium Management LLC C4 Therapeutics Inc [2023-07-25] 4.8
Soleus Capital Master Fund LP C4 Therapeutics Inc [2023-04-14] 5.0
ArrowMark Colorado Holdings LLC C4 Therapeutics Inc [2023-02-14] 11.85
ArrowMark Colorado Holdings LLC C4 Therapeutics Inc [2022-06-10] 11.09
Price T Rowe Associates Inc /MD/ C4 Therapeutics Inc [2022-02-14] 8.4
RTW Investments LP C4 Therapeutics Inc [2022-02-14] 5.1
BlackRock Inc C4 Therapeutics Inc [2022-02-04] 7.0
Perceptive Advisors LLC C4 Therapeutics Inc [2021-02-16] 7.3
Cobro Ventures Opportunity Fund LP C4 Therapeutics Inc [2020-10-16] 5.8
Cormorant Asset Management LP C4 Therapeutics Inc [2020-10-16] 1.21
Form 3/4/5 Filer 2011 - 2026
C4 Therapeutics Inc
Anderson Kenneth Carl
Grogan Donna Roy
Koppikar Utpal
Hoerter Steven L
Hughes Owen
Bessen Laura
Cooper Ronald Harold Wilfred
Fawell Stephen
Mahaney Paige
Boyle Scott N
Adams Kendra
Hirsch Andrew
Schick Kelly
Mossler Mark
Reyno Leonard
Siegel Jolie
Fisher Stewart
Salter Malcolm
Downey Bruce
Dubin Glenn
White Lauren
Crystal Adam
Cohen Marc A
Cohen Alain J
Prokupets Elena
Wahlberg Laura Jean
McKee William
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Hirsch Andrew
Common Stock
2026-02-15 Option exercise 20,400 $0.00
Hirsch Andrew
Common Stock
2026-02-15 Tax withheld 9,057 $1.89 17,118
Mahaney Paige
Common Stock
2026-02-14 Option exercise 7,050 $0.00
Hirsch Andrew
Common Stock
2026-02-14 Option exercise 81,725 $0.00
Reyno Leonard
Common Stock
2026-02-14 Option exercise 30,950 $0.00
Mahaney Paige
Common Stock
2026-02-14 Tax withheld 2,446 $1.89 4,623
Mossler Mark
Common Stock
2026-02-14 Option exercise 9,420 $0.00
Hirsch Andrew
Common Stock
2026-02-14 Tax withheld 39,154 $1.89 74,001
Boyle Scott N
Common Stock
2026-02-14 Option exercise 20,950 $0.00
Boyle Scott N
Common Stock
2026-02-14 Tax withheld 7,269 $1.89 13,738
Mossler Mark
Common Stock
2026-02-14 Tax withheld 3,268 $1.89 6,177
Schick Kelly
Common Stock
2026-02-14 Option exercise 20,950 $0.00
Schick Kelly
Common Stock
2026-02-14 Tax withheld 7,269 $1.89 13,738
Adams Kendra
Common Stock
2026-02-14 Option exercise 30,950 $0.00
Adams Kendra
Common Stock
2026-02-14 Tax withheld 15,381 $1.89 29,070
Reyno Leonard
Common Stock
2026-02-14 Tax withheld 16,579 $1.89 31,334
Boyle Scott N
Common Stock
2026-02-13 Grant 200,000 $0.00
Mossler Mark
Common Stock
2026-02-13 Grant 56,980 $0.00
Schick Kelly
Common Stock
2026-02-13 Grant 200,000 $0.00
Adams Kendra
Common Stock
2026-02-13 Tax withheld 1,863 $1.89 3,521
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 123 83,178,179
2025-12-31 101 80,044,857
2025-09-30 99 53,058,767
2025-06-30 101 54,928,210
2025-03-31 115 64,136,862
2024-12-31 117 65,166,084
2024-09-30 122 64,820,582
2024-06-30 116 61,347,361
2024-03-31 107 57,917,892
2023-12-31 93 45,840,799
2023-09-30 85 34,695,814
2023-06-30 101 31,443,323
Form 13F Holdings
Firm Period DFND Voting Shares
Wasatch Advisors LP [2026-06-30] SOLE 3,522,644 3,522,644
Congress Asset Management Co [2026-06-30] SOLE 864,137 1,003,437
[2026-06-30] SOLE 0 14,129
Owl Creek Wealth Partners LLC [2026-06-30] SOLE 0 2,140
Fortitude Family Office LLC [2026-06-30] SOLE 435 435
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com